← Back to Search

Behavioural Intervention

Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy

N/A
Waitlist Available
Led By Jennifer Gewandter
Research Sponsored by University of Rochester NCORP Research Base
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and 6 weeks

Summary

This trial is testing TENS as a possible treatment for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is when damage to nerves from chemotherapy affects the hands, feet, and/or legs. TENS is when electrical stimulation is passed through the skin to try and relieve pain.

Eligible Conditions
  • Peripheral Neuropathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Chemotherapy-induced Peripheral Neuropathy (CIPN) Symptoms
Secondary study objectives
Effect of TENS on Cramping
Effect of TENS on Hot/Burning Pain
Effect of TENS on Numbness
+2 more
Other study objectives
Analgesic use
CIPN
CIPN-interference in daily life
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group I (Active TENS)Experimental Treatment2 Interventions
Patients wear an active wireless TENS device 5 hours daily for up to 6 weeks in the absence of unacceptable toxicity.
Group II: Group II (Placebo TENS)Placebo Group2 Interventions
Patients wear a placebo wireless TENS device 5 hours daily for up to 6 weeks in the absence of unacceptable toxicity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcutaneous Electrical Nerve Stimulation
2022
N/A
~790

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,023,086 Total Patients Enrolled
14 Trials studying Peripheral Neuropathy
1,473 Patients Enrolled for Peripheral Neuropathy
University of Rochester NCORP Research BaseLead Sponsor
13 Previous Clinical Trials
8,992 Total Patients Enrolled
Jennifer GewandterPrincipal Investigator - University of Rochester NCORP Research Base
University of Rochester
~29 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top